Pharmaceuticals

Retinal Disorder Treatment Industry Insights: Market Forecast to 2029

November 7, 2025November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Retinal Disorder Treatment Market Size Likely To Evolve From 2025 Through 2034?

The retinal disorder treatment market has demonstrated significant growth in recent years. This market is set to expand from $12.59 billion in 2024 to $13.69 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.7%. Historically, this expansion has been driven by the introduction of anti-VEGF therapies, an aging population, a rising incidence of retinal disorders, improvements in diagnostic tools for early detection, increased awareness and screening programs, and wider access to healthcare services.

The retinal disorder treatment market is anticipated to undergo significant expansion in the coming years, with its size projected to reach $19.3 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is fueled by several factors, including patient-centric approaches in retinal healthcare, increasing global healthcare expenditure, a heightened focus on combination therapies for retinal disorders, the rise of home-based monitoring for these conditions, increasing adoption of implantable devices for retina treatment, and the integration of regenerative medicine in retina treatment. Prominent trends expected in the forecast period feature advancements in ophthalmic imaging technologies, the development of minimally invasive surgical techniques, the incorporation of artificial intelligence in diagnostics, breakthroughs in drug delivery technologies, the integration of virtual reality in retinal rehabilitation, enhanced collaboration between research institutions and pharmaceutical companies, and the development of gene therapies for genetic retinal diseases.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12701&type=smp

Which Drivers Are Supporting Growth Of The Retinal Disorder Treatment Market?

The increasing occurrence of retinal conditions is anticipated to drive expansion within the retinal disorder treatment market in the future. Retinal diseases are medical conditions impacting the retina, which is the light-sensitive tissue at the eye’s back, potentially leading to vision loss or significant visual impairment. Treatments for retinal disorders aid in managing and alleviating their symptoms through therapies like laser therapy, vitrectomy, and retinal implants. As an illustration, in January 2023, data from the International Agency for the Prevention of Blindness, a UK-based international alliance, indicated that age-related macular degeneration (AMD) is forecast to account for approximately 5% of all blindness worldwide. Furthermore, age-related macular degeneration diseases are projected to affect 288 million people by 2040. Consequently, the rising prevalence of retinal disorders is propelling the expansion of the retinal disorder treatment market.

What Are The Major Segments Identified In The Retinal Disorder Treatment Market?

The retinal disorder treatment market covered in this report is segmented –

1) By Type: Macular Degeneration, Diabetic Retinopathy, Other Types

2) By Dosage Form: Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Macular Degeneration: Dry Macular Degeneration, Wet Macular Degeneration

2) By Diabetic Retinopathy: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy

3) By Other Types: Retinal Detachment, Retinitis Pigmentosa, Uveitis, Other Retinal Disorders

What Are The Major Trends Driving The Growth Of The Retinal Disorder Treatment Market?

Product innovation is a key trend gaining traction in the retinal disorder treatment market. Major companies in this market are introducing new products to sustain their position. For instance, in January 2022, F. Hoffmann-La Roche AG, a Switzerland-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for Vabysmo, a bispecific antibody for treating neovascular or wet age-related macular degeneration (AMD) and diabetic macular edema (DME). This is the first injectable eye medication that targets and inhibits two disease pathways, angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A), which are linked to retinal diseases that can reduce vision. Clinical trials showed non-inferior vision improvements compared to conventional therapy, along with a good safety profile. This approval represents a significant advancement in treating retinal diseases, offering patients the potential for better eyesight and a lighter treatment burden.

Which Major Firms Are Strengthening Their Position In The Retinal Disorder Treatment Industry?

Major companies operating in the retinal disorder treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Kubota Pharmaceutical Holdings Co. Ltd, Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Adverum Biotechnologies Inc., Kodiak Sciences Inc., Acucela Inc., IVERIC bio Inc., Oxurion NV, Graybug Vision Inc., Icon Bioscience Inc., Clearside Biomedical Inc., Aerpio Pharmaceuticals Inc., Neurotech Pharmaceuticals Inc., Ophthotech Corporation, Opthea Limited, PanOptica Inc., ThromboGenics NV

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Retinal Disorder Treatment Market?

North America was the largest region in the retinal disorder treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Retinal Disorder Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12701&type=smp

Browse Through More Reports Similar to the Global Retinal Disorder Treatment Market 2025, By The Business Research Company

Retinal Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/retinal-biologics-global-market-report

Neuroprosthetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neuroprosthetics-global-market-report

Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-and-monitoring-ophthalmic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795